nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—ADRB1—stomach cancer	0.435	0.543	CbGaD
Labetalol—ADRB2—stomach cancer	0.366	0.457	CbGaD
Labetalol—Isoprenaline—MAPK1—stomach cancer	0.000641	0.0759	CrCbGaD
Labetalol—Dobutamine—CA2—stomach cancer	0.000484	0.0573	CrCbGaD
Labetalol—Fenoterol—ADRB1—stomach cancer	0.000391	0.0464	CrCbGaD
Labetalol—Arbutamine—ADRB1—stomach cancer	0.000366	0.0434	CrCbGaD
Labetalol—Formoterol—CYP2A6—stomach cancer	0.000366	0.0433	CrCbGaD
Labetalol—Arformoterol—CYP2A6—stomach cancer	0.000366	0.0433	CrCbGaD
Labetalol—Arformoterol—ADRB1—stomach cancer	0.000355	0.0421	CrCbGaD
Labetalol—Formoterol—ADRB1—stomach cancer	0.000355	0.0421	CrCbGaD
Labetalol—Benazepril—MTHFR—stomach cancer	0.000352	0.0417	CrCbGaD
Labetalol—Salmeterol—ADRB2—stomach cancer	0.000342	0.0405	CrCbGaD
Labetalol—Dobutamine—ADRB1—stomach cancer	0.000337	0.0399	CrCbGaD
Labetalol—Quinapril—ACE—stomach cancer	0.00033	0.0391	CrCbGaD
Labetalol—Fenoterol—ADRB2—stomach cancer	0.000329	0.039	CrCbGaD
Labetalol—Ritodrine—ADRB2—stomach cancer	0.000329	0.039	CrCbGaD
Labetalol—Arbutamine—ADRB2—stomach cancer	0.000308	0.0365	CrCbGaD
Labetalol—Arformoterol—ADRB2—stomach cancer	0.000299	0.0354	CrCbGaD
Labetalol—Formoterol—ADRB2—stomach cancer	0.000299	0.0354	CrCbGaD
Labetalol—Benazepril—ACE—stomach cancer	0.000287	0.034	CrCbGaD
Labetalol—Dobutamine—ADRB2—stomach cancer	0.000283	0.0336	CrCbGaD
Labetalol—Ketoprofen—CXCL8—stomach cancer	0.000242	0.0287	CrCbGaD
Labetalol—Mood swings—Doxorubicin—stomach cancer	0.000222	0.00144	CcSEcCtD
Labetalol—Mental disorder—Capecitabine—stomach cancer	0.00022	0.00143	CcSEcCtD
Labetalol—Feeling abnormal—Irinotecan—stomach cancer	0.00022	0.00143	CcSEcCtD
Labetalol—Erythema—Capecitabine—stomach cancer	0.000219	0.00142	CcSEcCtD
Labetalol—Dysuria—Methotrexate—stomach cancer	0.000219	0.00142	CcSEcCtD
Labetalol—Pain—Fluorouracil—stomach cancer	0.000219	0.00142	CcSEcCtD
Labetalol—Gastrointestinal pain—Irinotecan—stomach cancer	0.000218	0.00142	CcSEcCtD
Labetalol—Muscle spasms—Docetaxel—stomach cancer	0.000218	0.00141	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—stomach cancer	0.000217	0.0014	CcSEcCtD
Labetalol—Erectile dysfunction—Methotrexate—stomach cancer	0.000216	0.0014	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000214	0.00139	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—stomach cancer	0.000214	0.00139	CcSEcCtD
Labetalol—Angina pectoris—Epirubicin—stomach cancer	0.000213	0.00138	CcSEcCtD
Labetalol—Abdominal pain—Irinotecan—stomach cancer	0.000211	0.00137	CcSEcCtD
Labetalol—Body temperature increased—Irinotecan—stomach cancer	0.000211	0.00137	CcSEcCtD
Labetalol—Feeling abnormal—Fluorouracil—stomach cancer	0.000211	0.00137	CcSEcCtD
Labetalol—Muscle spasms—Capecitabine—stomach cancer	0.000211	0.00137	CcSEcCtD
Labetalol—Drowsiness—Methotrexate—stomach cancer	0.000209	0.00135	CcSEcCtD
Labetalol—Depression—Methotrexate—stomach cancer	0.000208	0.00135	CcSEcCtD
Labetalol—Vision blurred—Capecitabine—stomach cancer	0.000206	0.00134	CcSEcCtD
Labetalol—Tremor—Capecitabine—stomach cancer	0.000205	0.00133	CcSEcCtD
Labetalol—Dysuria—Epirubicin—stomach cancer	0.000205	0.00133	CcSEcCtD
Labetalol—Ill-defined disorder—Capecitabine—stomach cancer	0.000203	0.00132	CcSEcCtD
Labetalol—Urticaria—Fluorouracil—stomach cancer	0.000203	0.00132	CcSEcCtD
Labetalol—Syncope—Docetaxel—stomach cancer	0.000203	0.00132	CcSEcCtD
Labetalol—Body temperature increased—Fluorouracil—stomach cancer	0.000202	0.00131	CcSEcCtD
Labetalol—Sweating—Methotrexate—stomach cancer	0.0002	0.0013	CcSEcCtD
Labetalol—Palpitations—Docetaxel—stomach cancer	0.0002	0.0013	CcSEcCtD
Labetalol—Loss of consciousness—Docetaxel—stomach cancer	0.000199	0.00129	CcSEcCtD
Labetalol—Propafenone—ADRB1—stomach cancer	0.000198	0.0235	CrCbGaD
Labetalol—Malaise—Capecitabine—stomach cancer	0.000198	0.00128	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—stomach cancer	0.000197	0.00128	CcSEcCtD
Labetalol—Epistaxis—Methotrexate—stomach cancer	0.000197	0.00128	CcSEcCtD
Labetalol—Vertigo—Capecitabine—stomach cancer	0.000197	0.00128	CcSEcCtD
Labetalol—Hypersensitivity—Irinotecan—stomach cancer	0.000197	0.00128	CcSEcCtD
Labetalol—Syncope—Capecitabine—stomach cancer	0.000196	0.00127	CcSEcCtD
Labetalol—Hypertension—Docetaxel—stomach cancer	0.000195	0.00127	CcSEcCtD
Labetalol—Drowsiness—Epirubicin—stomach cancer	0.000195	0.00127	CcSEcCtD
Labetalol—Agranulocytosis—Methotrexate—stomach cancer	0.000195	0.00126	CcSEcCtD
Labetalol—Palpitations—Capecitabine—stomach cancer	0.000194	0.00126	CcSEcCtD
Labetalol—Loss of consciousness—Capecitabine—stomach cancer	0.000193	0.00125	CcSEcCtD
Labetalol—Asthenia—Irinotecan—stomach cancer	0.000192	0.00124	CcSEcCtD
Labetalol—Isoprenaline—ADRB1—stomach cancer	0.000191	0.0226	CrCbGaD
Labetalol—Jaundice—Epirubicin—stomach cancer	0.00019	0.00123	CcSEcCtD
Labetalol—Dysuria—Doxorubicin—stomach cancer	0.00019	0.00123	CcSEcCtD
Labetalol—Hypertension—Capecitabine—stomach cancer	0.000189	0.00123	CcSEcCtD
Labetalol—Hypersensitivity—Fluorouracil—stomach cancer	0.000189	0.00122	CcSEcCtD
Labetalol—Hepatitis—Methotrexate—stomach cancer	0.000187	0.00122	CcSEcCtD
Labetalol—Sweating—Epirubicin—stomach cancer	0.000187	0.00121	CcSEcCtD
Labetalol—Confusional state—Docetaxel—stomach cancer	0.000186	0.00121	CcSEcCtD
Labetalol—Oedema—Docetaxel—stomach cancer	0.000185	0.0012	CcSEcCtD
Labetalol—Anaphylactic shock—Docetaxel—stomach cancer	0.000185	0.0012	CcSEcCtD
Labetalol—Discomfort—Capecitabine—stomach cancer	0.000184	0.0012	CcSEcCtD
Labetalol—Epistaxis—Epirubicin—stomach cancer	0.000184	0.00119	CcSEcCtD
Labetalol—Diarrhoea—Irinotecan—stomach cancer	0.000183	0.00119	CcSEcCtD
Labetalol—Agranulocytosis—Epirubicin—stomach cancer	0.000182	0.00118	CcSEcCtD
Labetalol—Shock—Docetaxel—stomach cancer	0.000182	0.00118	CcSEcCtD
Labetalol—Pruritus—Fluorouracil—stomach cancer	0.000181	0.00117	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—stomach cancer	0.000181	0.00117	CcSEcCtD
Labetalol—Visual impairment—Methotrexate—stomach cancer	0.000181	0.00117	CcSEcCtD
Labetalol—Confusional state—Capecitabine—stomach cancer	0.00018	0.00117	CcSEcCtD
Labetalol—Oedema—Capecitabine—stomach cancer	0.000179	0.00116	CcSEcCtD
Labetalol—Bradycardia—Epirubicin—stomach cancer	0.000178	0.00116	CcSEcCtD
Labetalol—Mirabegron—ALB—stomach cancer	0.000178	0.0211	CrCbGaD
Labetalol—Dizziness—Irinotecan—stomach cancer	0.000177	0.00115	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—stomach cancer	0.000176	0.00114	CcSEcCtD
Labetalol—Shock—Capecitabine—stomach cancer	0.000176	0.00114	CcSEcCtD
Labetalol—Hepatitis—Epirubicin—stomach cancer	0.000175	0.00114	CcSEcCtD
Labetalol—Diarrhoea—Fluorouracil—stomach cancer	0.000175	0.00114	CcSEcCtD
Labetalol—Hypoaesthesia—Epirubicin—stomach cancer	0.000174	0.00113	CcSEcCtD
Labetalol—Sweating—Doxorubicin—stomach cancer	0.000173	0.00112	CcSEcCtD
Labetalol—Hyperhidrosis—Capecitabine—stomach cancer	0.000173	0.00112	CcSEcCtD
Labetalol—Oedema peripheral—Epirubicin—stomach cancer	0.000173	0.00112	CcSEcCtD
Labetalol—Hypotension—Docetaxel—stomach cancer	0.000173	0.00112	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—stomach cancer	0.00017	0.00111	CcSEcCtD
Labetalol—Vomiting—Irinotecan—stomach cancer	0.00017	0.0011	CcSEcCtD
Labetalol—Dizziness—Fluorouracil—stomach cancer	0.000169	0.0011	CcSEcCtD
Labetalol—Visual impairment—Epirubicin—stomach cancer	0.000169	0.0011	CcSEcCtD
Labetalol—Agranulocytosis—Doxorubicin—stomach cancer	0.000169	0.00109	CcSEcCtD
Labetalol—Rash—Irinotecan—stomach cancer	0.000168	0.00109	CcSEcCtD
Labetalol—Dermatitis—Irinotecan—stomach cancer	0.000168	0.00109	CcSEcCtD
Labetalol—Headache—Irinotecan—stomach cancer	0.000167	0.00109	CcSEcCtD
Labetalol—Hypotension—Capecitabine—stomach cancer	0.000167	0.00108	CcSEcCtD
Labetalol—Paraesthesia—Docetaxel—stomach cancer	0.000166	0.00108	CcSEcCtD
Labetalol—Alopecia—Methotrexate—stomach cancer	0.000166	0.00107	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—stomach cancer	0.000165	0.00107	CcSEcCtD
Labetalol—Dyspnoea—Docetaxel—stomach cancer	0.000165	0.00107	CcSEcCtD
Labetalol—Somnolence—Docetaxel—stomach cancer	0.000164	0.00106	CcSEcCtD
Labetalol—Mental disorder—Methotrexate—stomach cancer	0.000164	0.00106	CcSEcCtD
Labetalol—Erythema—Methotrexate—stomach cancer	0.000163	0.00106	CcSEcCtD
Labetalol—Flushing—Epirubicin—stomach cancer	0.000163	0.00106	CcSEcCtD
Labetalol—Vomiting—Fluorouracil—stomach cancer	0.000163	0.00106	CcSEcCtD
Labetalol—Dyspepsia—Docetaxel—stomach cancer	0.000163	0.00105	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—stomach cancer	0.000162	0.00105	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—stomach cancer	0.000161	0.00105	CcSEcCtD
Labetalol—Rash—Fluorouracil—stomach cancer	0.000161	0.00105	CcSEcCtD
Labetalol—Dermatitis—Fluorouracil—stomach cancer	0.000161	0.00105	CcSEcCtD
Labetalol—Isoprenaline—ADRB2—stomach cancer	0.000161	0.019	CrCbGaD
Labetalol—Paraesthesia—Capecitabine—stomach cancer	0.000161	0.00104	CcSEcCtD
Labetalol—Headache—Fluorouracil—stomach cancer	0.00016	0.00104	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—stomach cancer	0.00016	0.00104	CcSEcCtD
Labetalol—Dyspnoea—Capecitabine—stomach cancer	0.000159	0.00103	CcSEcCtD
Labetalol—Fatigue—Docetaxel—stomach cancer	0.000159	0.00103	CcSEcCtD
Labetalol—Nausea—Irinotecan—stomach cancer	0.000159	0.00103	CcSEcCtD
Labetalol—Constipation—Docetaxel—stomach cancer	0.000158	0.00102	CcSEcCtD
Labetalol—Pain—Docetaxel—stomach cancer	0.000158	0.00102	CcSEcCtD
Labetalol—Dyspepsia—Capecitabine—stomach cancer	0.000157	0.00102	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—stomach cancer	0.000156	0.00101	CcSEcCtD
Labetalol—Alopecia—Epirubicin—stomach cancer	0.000155	0.001	CcSEcCtD
Labetalol—Fatigue—Capecitabine—stomach cancer	0.000154	0.001	CcSEcCtD
Labetalol—Vision blurred—Methotrexate—stomach cancer	0.000154	0.000997	CcSEcCtD
Labetalol—Mental disorder—Epirubicin—stomach cancer	0.000154	0.000996	CcSEcCtD
Labetalol—Pain—Capecitabine—stomach cancer	0.000153	0.000992	CcSEcCtD
Labetalol—Constipation—Capecitabine—stomach cancer	0.000153	0.000992	CcSEcCtD
Labetalol—Erythema—Epirubicin—stomach cancer	0.000153	0.00099	CcSEcCtD
Labetalol—Feeling abnormal—Docetaxel—stomach cancer	0.000152	0.000987	CcSEcCtD
Labetalol—Nausea—Fluorouracil—stomach cancer	0.000152	0.000986	CcSEcCtD
Labetalol—Ill-defined disorder—Methotrexate—stomach cancer	0.000151	0.000981	CcSEcCtD
Labetalol—Gastrointestinal pain—Docetaxel—stomach cancer	0.000151	0.000979	CcSEcCtD
Labetalol—Flushing—Doxorubicin—stomach cancer	0.000151	0.000977	CcSEcCtD
Labetalol—Feeling abnormal—Capecitabine—stomach cancer	0.000147	0.000956	CcSEcCtD
Labetalol—Malaise—Methotrexate—stomach cancer	0.000147	0.000954	CcSEcCtD
Labetalol—Muscle spasms—Epirubicin—stomach cancer	0.000147	0.000952	CcSEcCtD
Labetalol—Vertigo—Methotrexate—stomach cancer	0.000147	0.00095	CcSEcCtD
Labetalol—Gastrointestinal pain—Capecitabine—stomach cancer	0.000146	0.000948	CcSEcCtD
Labetalol—Body temperature increased—Docetaxel—stomach cancer	0.000146	0.000947	CcSEcCtD
Labetalol—Abdominal pain—Docetaxel—stomach cancer	0.000146	0.000947	CcSEcCtD
Labetalol—Salsalate—PTGS2—stomach cancer	0.000145	0.0172	CrCbGaD
Labetalol—Vision blurred—Epirubicin—stomach cancer	0.000144	0.000933	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—stomach cancer	0.000143	0.00093	CcSEcCtD
Labetalol—Mental disorder—Doxorubicin—stomach cancer	0.000142	0.000922	CcSEcCtD
Labetalol—Urticaria—Capecitabine—stomach cancer	0.000142	0.000921	CcSEcCtD
Labetalol—Ill-defined disorder—Epirubicin—stomach cancer	0.000142	0.000919	CcSEcCtD
Labetalol—Abdominal pain—Capecitabine—stomach cancer	0.000141	0.000917	CcSEcCtD
Labetalol—Body temperature increased—Capecitabine—stomach cancer	0.000141	0.000917	CcSEcCtD
Labetalol—Erythema—Doxorubicin—stomach cancer	0.000141	0.000916	CcSEcCtD
Labetalol—Malaise—Epirubicin—stomach cancer	0.000138	0.000893	CcSEcCtD
Labetalol—Discomfort—Methotrexate—stomach cancer	0.000137	0.00089	CcSEcCtD
Labetalol—Vertigo—Epirubicin—stomach cancer	0.000137	0.000889	CcSEcCtD
Labetalol—Syncope—Epirubicin—stomach cancer	0.000137	0.000888	CcSEcCtD
Labetalol—Hypersensitivity—Docetaxel—stomach cancer	0.000136	0.000883	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—stomach cancer	0.000136	0.000881	CcSEcCtD
Labetalol—Palpitations—Epirubicin—stomach cancer	0.000135	0.000875	CcSEcCtD
Labetalol—Confusional state—Methotrexate—stomach cancer	0.000134	0.00087	CcSEcCtD
Labetalol—Loss of consciousness—Epirubicin—stomach cancer	0.000134	0.00087	CcSEcCtD
Labetalol—Anaphylactic shock—Methotrexate—stomach cancer	0.000133	0.000863	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—stomach cancer	0.000133	0.000863	CcSEcCtD
Labetalol—Asthenia—Docetaxel—stomach cancer	0.000133	0.000859	CcSEcCtD
Labetalol—Hypertension—Epirubicin—stomach cancer	0.000132	0.000855	CcSEcCtD
Labetalol—Hypersensitivity—Capecitabine—stomach cancer	0.000132	0.000854	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—stomach cancer	0.000131	0.00085	CcSEcCtD
Labetalol—Pruritus—Docetaxel—stomach cancer	0.000131	0.000847	CcSEcCtD
Labetalol—Hyperhidrosis—Methotrexate—stomach cancer	0.000129	0.000835	CcSEcCtD
Labetalol—Discomfort—Epirubicin—stomach cancer	0.000128	0.000833	CcSEcCtD
Labetalol—Asthenia—Capecitabine—stomach cancer	0.000128	0.000832	CcSEcCtD
Labetalol—Malaise—Doxorubicin—stomach cancer	0.000127	0.000826	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—stomach cancer	0.000127	0.000823	CcSEcCtD
Labetalol—Syncope—Doxorubicin—stomach cancer	0.000127	0.000821	CcSEcCtD
Labetalol—Pruritus—Capecitabine—stomach cancer	0.000127	0.00082	CcSEcCtD
Labetalol—Diarrhoea—Docetaxel—stomach cancer	0.000126	0.00082	CcSEcCtD
Labetalol—Confusional state—Epirubicin—stomach cancer	0.000126	0.000815	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—stomach cancer	0.000125	0.000809	CcSEcCtD
Labetalol—Oedema—Epirubicin—stomach cancer	0.000125	0.000808	CcSEcCtD
Labetalol—Anaphylactic shock—Epirubicin—stomach cancer	0.000125	0.000808	CcSEcCtD
Labetalol—Hypotension—Methotrexate—stomach cancer	0.000124	0.000807	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—stomach cancer	0.000124	0.000805	CcSEcCtD
Labetalol—Shock—Epirubicin—stomach cancer	0.000123	0.000795	CcSEcCtD
Labetalol—Diarrhoea—Capecitabine—stomach cancer	0.000122	0.000793	CcSEcCtD
Labetalol—Dizziness—Docetaxel—stomach cancer	0.000122	0.000792	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—stomach cancer	0.000122	0.000791	CcSEcCtD
Labetalol—Hyperhidrosis—Epirubicin—stomach cancer	0.00012	0.000781	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—stomach cancer	0.00012	0.0142	CrCbGaD
Labetalol—Paraesthesia—Methotrexate—stomach cancer	0.00012	0.000775	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—stomach cancer	0.000119	0.00077	CcSEcCtD
Labetalol—Dyspnoea—Methotrexate—stomach cancer	0.000119	0.00077	CcSEcCtD
Labetalol—Somnolence—Methotrexate—stomach cancer	0.000118	0.000767	CcSEcCtD
Labetalol—Dizziness—Capecitabine—stomach cancer	0.000118	0.000767	CcSEcCtD
Labetalol—Vomiting—Docetaxel—stomach cancer	0.000117	0.000762	CcSEcCtD
Labetalol—Dyspepsia—Methotrexate—stomach cancer	0.000117	0.00076	CcSEcCtD
Labetalol—Rash—Docetaxel—stomach cancer	0.000116	0.000755	CcSEcCtD
Labetalol—Hypotension—Epirubicin—stomach cancer	0.000116	0.000755	CcSEcCtD
Labetalol—Dermatitis—Docetaxel—stomach cancer	0.000116	0.000755	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—stomach cancer	0.000116	0.000754	CcSEcCtD
Labetalol—Headache—Docetaxel—stomach cancer	0.000116	0.00075	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—stomach cancer	0.000115	0.000748	CcSEcCtD
Labetalol—Oedema—Doxorubicin—stomach cancer	0.000115	0.000748	CcSEcCtD
Labetalol—Fatigue—Methotrexate—stomach cancer	0.000115	0.000744	CcSEcCtD
Labetalol—Pain—Methotrexate—stomach cancer	0.000114	0.000738	CcSEcCtD
Labetalol—Vomiting—Capecitabine—stomach cancer	0.000114	0.000737	CcSEcCtD
Labetalol—Shock—Doxorubicin—stomach cancer	0.000113	0.000735	CcSEcCtD
Labetalol—Rash—Capecitabine—stomach cancer	0.000113	0.000731	CcSEcCtD
Labetalol—Dermatitis—Capecitabine—stomach cancer	0.000113	0.000731	CcSEcCtD
Labetalol—Headache—Capecitabine—stomach cancer	0.000112	0.000727	CcSEcCtD
Labetalol—Paraesthesia—Epirubicin—stomach cancer	0.000112	0.000725	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—stomach cancer	0.000111	0.000723	CcSEcCtD
Labetalol—Dyspnoea—Epirubicin—stomach cancer	0.000111	0.00072	CcSEcCtD
Labetalol—Somnolence—Epirubicin—stomach cancer	0.000111	0.000718	CcSEcCtD
Labetalol—Nausea—Docetaxel—stomach cancer	0.00011	0.000711	CcSEcCtD
Labetalol—Feeling abnormal—Methotrexate—stomach cancer	0.00011	0.000711	CcSEcCtD
Labetalol—Dyspepsia—Epirubicin—stomach cancer	0.00011	0.000711	CcSEcCtD
Labetalol—Gastrointestinal pain—Methotrexate—stomach cancer	0.000109	0.000706	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—stomach cancer	0.000108	0.000699	CcSEcCtD
Labetalol—Fatigue—Epirubicin—stomach cancer	0.000107	0.000697	CcSEcCtD
Labetalol—Fenoprofen—ALB—stomach cancer	0.000107	0.0126	CrCbGaD
Labetalol—Pain—Epirubicin—stomach cancer	0.000107	0.000691	CcSEcCtD
Labetalol—Constipation—Epirubicin—stomach cancer	0.000107	0.000691	CcSEcCtD
Labetalol—Nausea—Capecitabine—stomach cancer	0.000106	0.000689	CcSEcCtD
Labetalol—Urticaria—Methotrexate—stomach cancer	0.000106	0.000686	CcSEcCtD
Labetalol—Abdominal pain—Methotrexate—stomach cancer	0.000105	0.000682	CcSEcCtD
Labetalol—Body temperature increased—Methotrexate—stomach cancer	0.000105	0.000682	CcSEcCtD
Labetalol—Paraesthesia—Doxorubicin—stomach cancer	0.000103	0.000671	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—stomach cancer	0.000103	0.000666	CcSEcCtD
Labetalol—Feeling abnormal—Epirubicin—stomach cancer	0.000103	0.000666	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—stomach cancer	0.000102	0.000665	CcSEcCtD
Labetalol—Gastrointestinal pain—Epirubicin—stomach cancer	0.000102	0.000661	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—stomach cancer	0.000101	0.000658	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—stomach cancer	9.94e-05	0.000645	CcSEcCtD
Labetalol—Urticaria—Epirubicin—stomach cancer	9.9e-05	0.000642	CcSEcCtD
Labetalol—Pain—Doxorubicin—stomach cancer	9.86e-05	0.000639	CcSEcCtD
Labetalol—Constipation—Doxorubicin—stomach cancer	9.86e-05	0.000639	CcSEcCtD
Labetalol—Abdominal pain—Epirubicin—stomach cancer	9.85e-05	0.000639	CcSEcCtD
Labetalol—Body temperature increased—Epirubicin—stomach cancer	9.85e-05	0.000639	CcSEcCtD
Labetalol—Hypersensitivity—Methotrexate—stomach cancer	9.81e-05	0.000636	CcSEcCtD
Labetalol—Asthenia—Methotrexate—stomach cancer	9.55e-05	0.000619	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—stomach cancer	9.5e-05	0.000616	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—stomach cancer	9.42e-05	0.000611	CcSEcCtD
Labetalol—Pruritus—Methotrexate—stomach cancer	9.42e-05	0.000611	CcSEcCtD
Labetalol—Hypersensitivity—Epirubicin—stomach cancer	9.18e-05	0.000595	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—stomach cancer	9.16e-05	0.000594	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—stomach cancer	9.11e-05	0.000591	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—stomach cancer	9.11e-05	0.000591	CcSEcCtD
Labetalol—Diarrhoea—Methotrexate—stomach cancer	9.11e-05	0.000591	CcSEcCtD
Labetalol—Asthenia—Epirubicin—stomach cancer	8.94e-05	0.00058	CcSEcCtD
Labetalol—Pruritus—Epirubicin—stomach cancer	8.81e-05	0.000572	CcSEcCtD
Labetalol—Dizziness—Methotrexate—stomach cancer	8.8e-05	0.000571	CcSEcCtD
Labetalol—Diarrhoea—Epirubicin—stomach cancer	8.52e-05	0.000553	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—stomach cancer	8.49e-05	0.000551	CcSEcCtD
Labetalol—Vomiting—Methotrexate—stomach cancer	8.46e-05	0.000549	CcSEcCtD
Labetalol—Rash—Methotrexate—stomach cancer	8.39e-05	0.000544	CcSEcCtD
Labetalol—Dermatitis—Methotrexate—stomach cancer	8.38e-05	0.000544	CcSEcCtD
Labetalol—Headache—Methotrexate—stomach cancer	8.34e-05	0.000541	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—stomach cancer	8.27e-05	0.000536	CcSEcCtD
Labetalol—Dizziness—Epirubicin—stomach cancer	8.24e-05	0.000534	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—stomach cancer	8.15e-05	0.000529	CcSEcCtD
Labetalol—Vomiting—Epirubicin—stomach cancer	7.92e-05	0.000514	CcSEcCtD
Labetalol—Nausea—Methotrexate—stomach cancer	7.91e-05	0.000513	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—stomach cancer	7.89e-05	0.000511	CcSEcCtD
Labetalol—Rash—Epirubicin—stomach cancer	7.85e-05	0.000509	CcSEcCtD
Labetalol—Dermatitis—Epirubicin—stomach cancer	7.85e-05	0.000509	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—stomach cancer	7.8e-05	0.00925	CrCbGaD
Labetalol—Headache—Epirubicin—stomach cancer	7.8e-05	0.000506	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—stomach cancer	7.62e-05	0.000494	CcSEcCtD
Labetalol—Nausea—Epirubicin—stomach cancer	7.4e-05	0.00048	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—stomach cancer	7.33e-05	0.000475	CcSEcCtD
Labetalol—Rash—Doxorubicin—stomach cancer	7.27e-05	0.000471	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—stomach cancer	7.26e-05	0.000471	CcSEcCtD
Labetalol—Headache—Doxorubicin—stomach cancer	7.22e-05	0.000468	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—stomach cancer	7.06e-05	0.00837	CrCbGaD
Labetalol—Flurbiprofen—ALB—stomach cancer	6.95e-05	0.00824	CrCbGaD
Labetalol—Nausea—Doxorubicin—stomach cancer	6.85e-05	0.000444	CcSEcCtD
Labetalol—Ketoprofen—ALB—stomach cancer	6.29e-05	0.00746	CrCbGaD
Labetalol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	2.81e-05	0.000789	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HTR1A—stomach cancer	2.8e-05	0.000785	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	2.75e-05	0.000772	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	2.74e-05	0.000769	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	2.72e-05	0.000762	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PRKCB—stomach cancer	2.71e-05	0.00076	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ANXA1—stomach cancer	2.71e-05	0.000758	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NDUFV1—stomach cancer	2.7e-05	0.000758	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NDUFS1—stomach cancer	2.7e-05	0.000758	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	2.68e-05	0.000753	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	2.66e-05	0.000745	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KISS1—stomach cancer	2.65e-05	0.000743	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RNF43—stomach cancer	2.65e-05	0.000743	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.64e-05	0.000739	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRB1—stomach cancer	2.62e-05	0.000734	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RNF43—stomach cancer	2.59e-05	0.000727	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KISS1—stomach cancer	2.59e-05	0.000727	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.58e-05	0.000723	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	2.57e-05	0.000722	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RPS6—stomach cancer	2.5e-05	0.000702	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PRKCB—stomach cancer	2.46e-05	0.00069	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6ST—stomach cancer	2.45e-05	0.000688	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—BLVRB—stomach cancer	2.41e-05	0.000675	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PGLS—stomach cancer	2.41e-05	0.000675	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FST—stomach cancer	2.36e-05	0.000662	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	2.35e-05	0.000658	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	2.31e-05	0.000648	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FST—stomach cancer	2.31e-05	0.000648	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HBEGF—stomach cancer	2.3e-05	0.000645	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPAP2A—stomach cancer	2.3e-05	0.000644	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RGS2—stomach cancer	2.28e-05	0.000639	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GAST—stomach cancer	2.28e-05	0.000639	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	2.26e-05	0.000634	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GAST—stomach cancer	2.23e-05	0.000625	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RGS2—stomach cancer	2.23e-05	0.000625	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6R—stomach cancer	2.19e-05	0.000614	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—RHOA—stomach cancer	2.18e-05	0.00061	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGG—stomach cancer	2.16e-05	0.000606	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	2.13e-05	0.000598	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRB2—stomach cancer	2.12e-05	0.000595	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGG—stomach cancer	2.11e-05	0.000592	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	2.09e-05	0.000586	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PPP2R1A—stomach cancer	2.08e-05	0.000583	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	2.08e-05	0.000583	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CKB—stomach cancer	2.05e-05	0.000574	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CA1—stomach cancer	2.05e-05	0.000574	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NDUFA2—stomach cancer	2.05e-05	0.000574	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FBP1—stomach cancer	2.05e-05	0.000574	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	2.04e-05	0.000573	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	2.03e-05	0.00057	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RBP4—stomach cancer	2.01e-05	0.000563	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	2.01e-05	0.000563	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—RHOA—stomach cancer	1.98e-05	0.000554	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RBP4—stomach cancer	1.96e-05	0.000551	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	1.96e-05	0.00055	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SMAD4—stomach cancer	1.93e-05	0.000541	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLIN2—stomach cancer	1.93e-05	0.00054	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCL8—stomach cancer	1.91e-05	0.000536	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CA2—stomach cancer	1.87e-05	0.000525	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FYN—stomach cancer	1.83e-05	0.000514	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PGAM1—stomach cancer	1.83e-05	0.000512	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NT5E—stomach cancer	1.83e-05	0.000512	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALDH7A1—stomach cancer	1.74e-05	0.000488	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PLCE1—stomach cancer	1.74e-05	0.000488	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCL8—stomach cancer	1.74e-05	0.000487	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	1.73e-05	0.000484	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	1.73e-05	0.000484	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—FGFR2—stomach cancer	1.72e-05	0.000483	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—BMP2—stomach cancer	1.71e-05	0.000479	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—F2R—stomach cancer	1.71e-05	0.000479	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	1.69e-05	0.000474	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	1.69e-05	0.000474	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	1.68e-05	0.000471	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—BMP2—stomach cancer	1.67e-05	0.000468	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—F2R—stomach cancer	1.67e-05	0.000468	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—UMPS—stomach cancer	1.67e-05	0.000468	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	1.66e-05	0.000466	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	1.64e-05	0.000461	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	1.63e-05	0.000456	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	1.61e-05	0.000451	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	1.61e-05	0.00045	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IRS2—stomach cancer	1.58e-05	0.000442	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	1.57e-05	0.000441	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	1.57e-05	0.00044	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ECHS1—stomach cancer	1.55e-05	0.000435	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PDHA1—stomach cancer	1.55e-05	0.000435	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CAV1—stomach cancer	1.53e-05	0.000429	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOA1—stomach cancer	1.53e-05	0.000428	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	1.52e-05	0.000426	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RPS6—stomach cancer	1.49e-05	0.000416	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	1.46e-05	0.00041	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TYMP—stomach cancer	1.46e-05	0.000409	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—FADS1—stomach cancer	1.46e-05	0.000409	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.46e-05	0.000408	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PRKCB—stomach cancer	1.45e-05	0.000408	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.45e-05	0.000407	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6ST—stomach cancer	1.45e-05	0.000406	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.43e-05	0.000401	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.42e-05	0.000399	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APC—stomach cancer	1.39e-05	0.00039	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SREBF2—stomach cancer	1.37e-05	0.000383	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.37e-05	0.000383	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—RORA—stomach cancer	1.35e-05	0.000379	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.34e-05	0.000374	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—MAPK3—stomach cancer	1.33e-05	0.000374	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.3e-05	0.000364	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6R—stomach cancer	1.29e-05	0.000362	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.29e-05	0.000362	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.27e-05	0.000356	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—MAPK1—stomach cancer	1.27e-05	0.000356	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—EGFR—stomach cancer	1.27e-05	0.000356	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALDOB—stomach cancer	1.27e-05	0.000355	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.26e-05	0.000354	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1.26e-05	0.000353	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	1.23e-05	0.000346	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CA—stomach cancer	1.21e-05	0.00034	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SERPINE1—stomach cancer	1.21e-05	0.000339	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	1.21e-05	0.000339	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—KRAS—stomach cancer	1.2e-05	0.000336	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALOX5—stomach cancer	1.18e-05	0.00033	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	1.17e-05	0.000329	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RHOA—stomach cancer	1.17e-05	0.000327	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DPYD—stomach cancer	1.16e-05	0.000325	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOS3—stomach cancer	1.16e-05	0.000324	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	1.15e-05	0.000322	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	1.15e-05	0.000321	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	1.13e-05	0.000318	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	1.12e-05	0.000314	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	1.11e-05	0.000311	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CA—stomach cancer	1.1e-05	0.000309	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FYN—stomach cancer	1.09e-05	0.000305	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ERBB2—stomach cancer	1.08e-05	0.000303	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FYN—stomach cancer	1.06e-05	0.000298	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	1.03e-05	0.000289	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL8—stomach cancer	1.03e-05	0.000287	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTT1—stomach cancer	1.02e-05	0.000287	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	1.02e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HRAS—stomach cancer	1.02e-05	0.000286	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.01e-05	0.000284	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	1.01e-05	0.000282	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CDKN1B—stomach cancer	1e-05	0.000281	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	1e-05	0.00028	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKR1C3—stomach cancer	9.84e-06	0.000276	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—stomach cancer	9.75e-06	0.000273	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ENO1—stomach cancer	9.59e-06	0.000269	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCND1—stomach cancer	9.55e-06	0.000268	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—JUN—stomach cancer	9.53e-06	0.000267	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IRS2—stomach cancer	9.36e-06	0.000262	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—stomach cancer	9.27e-06	0.00026	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CDKN1A—stomach cancer	9.24e-06	0.000259	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IRS2—stomach cancer	9.15e-06	0.000257	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CAV1—stomach cancer	9.07e-06	0.000254	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOA1—stomach cancer	9.05e-06	0.000254	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK8—stomach cancer	9.02e-06	0.000253	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CAV1—stomach cancer	8.87e-06	0.000249	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOA1—stomach cancer	8.85e-06	0.000248	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	8.64e-06	0.000242	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	8.6e-06	0.000241	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CD44—stomach cancer	8.51e-06	0.000238	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	8.45e-06	0.000237	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	8.41e-06	0.000236	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—stomach cancer	8.33e-06	0.000233	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APC—stomach cancer	8.26e-06	0.000232	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STAT3—stomach cancer	8.24e-06	0.000231	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APC—stomach cancer	8.08e-06	0.000227	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	7.91e-06	0.000222	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK3—stomach cancer	7.88e-06	0.000221	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	7.74e-06	0.000217	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6R—stomach cancer	7.67e-06	0.000215	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MYC—stomach cancer	7.66e-06	0.000215	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	7.53e-06	0.000211	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	7.53e-06	0.000211	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6R—stomach cancer	7.51e-06	0.00021	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAPK1—stomach cancer	7.49e-06	0.00021	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGFR—stomach cancer	7.49e-06	0.00021	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	7.37e-06	0.000207	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	7.36e-06	0.000206	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPP2R1A—stomach cancer	7.23e-06	0.000203	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	7.2e-06	0.000202	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	7.19e-06	0.000201	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	7.11e-06	0.000199	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTP1—stomach cancer	7.1e-06	0.000199	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KRAS—stomach cancer	7.08e-06	0.000198	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	7.04e-06	0.000197	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	7.03e-06	0.000197	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—HMOX1—stomach cancer	7e-06	0.000196	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	6.96e-06	0.000195	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RHOA—stomach cancer	6.93e-06	0.000194	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOS3—stomach cancer	6.86e-06	0.000192	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RHOA—stomach cancer	6.78e-06	0.00019	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOS3—stomach cancer	6.71e-06	0.000188	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TYMS—stomach cancer	6.6e-06	0.000185	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	6.53e-06	0.000183	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GSTM1—stomach cancer	6.52e-06	0.000183	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CA—stomach cancer	6.5e-06	0.000182	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	6.42e-06	0.00018	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	6.39e-06	0.000179	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TP53—stomach cancer	6.29e-06	0.000176	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	6.28e-06	0.000176	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ERCC2—stomach cancer	6.13e-06	0.000172	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	6.08e-06	0.000171	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	6.05e-06	0.000169	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HRAS—stomach cancer	6.02e-06	0.000169	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	5.95e-06	0.000167	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	5.94e-06	0.000167	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	5.91e-06	0.000166	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	5.81e-06	0.000163	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—stomach cancer	5.79e-06	0.000162	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—MTHFR—stomach cancer	5.76e-06	0.000162	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—stomach cancer	5.76e-06	0.000161	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCND1—stomach cancer	5.67e-06	0.000159	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—stomach cancer	5.66e-06	0.000159	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JUN—stomach cancer	5.66e-06	0.000159	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCND1—stomach cancer	5.55e-06	0.000155	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JUN—stomach cancer	5.53e-06	0.000155	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—stomach cancer	5.5e-06	0.000154	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	5.48e-06	0.000154	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—stomach cancer	5.38e-06	0.000151	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	5.36e-06	0.00015	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	5.35e-06	0.00015	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CAV1—stomach cancer	5.32e-06	0.000149	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOA1—stomach cancer	5.3e-06	0.000149	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	5.24e-06	0.000147	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	4.94e-06	0.000139	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT3—stomach cancer	4.89e-06	0.000137	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	4.83e-06	0.000136	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT3—stomach cancer	4.79e-06	0.000134	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	4.68e-06	0.000131	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—stomach cancer	4.67e-06	0.000131	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	4.57e-06	0.000128	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MYC—stomach cancer	4.55e-06	0.000127	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	4.45e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MYC—stomach cancer	4.45e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGFR—stomach cancer	4.45e-06	0.000125	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	4.35e-06	0.000122	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGFR—stomach cancer	4.35e-06	0.000122	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KRAS—stomach cancer	4.2e-06	0.000118	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—stomach cancer	4.2e-06	0.000118	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KRAS—stomach cancer	4.11e-06	0.000115	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—NOS3—stomach cancer	4.02e-06	0.000113	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	3.86e-06	0.000108	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	3.78e-06	0.000106	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TP53—stomach cancer	3.73e-06	0.000105	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—stomach cancer	3.68e-06	0.000103	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TP53—stomach cancer	3.65e-06	0.000102	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HRAS—stomach cancer	3.57e-06	0.0001	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HRAS—stomach cancer	3.49e-06	9.79e-05	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—stomach cancer	3.42e-06	9.58e-05	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—stomach cancer	3.34e-06	9.37e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.26e-06	6.34e-05	CbGpPWpGaD
